[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369754-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369754-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-immune-microenvironment-in-cervical-cancer-current-research-and-advances","Targeting immune microenvironment in cervical cancer - current research and advances","","The immune microenvironment is pivotal in cervical cancer pathogenesis and treatment response. This review analyzes the cellular and molecular components of the tumor immune microenvironment (TIME), including immune cell infiltration patterns (T cells, B cells, NK cells, DCs, TAMs), immune checkpoint molecules, and cytokine/chemokine interaction networks. It highlights how recent high-resolution spatial mapping and single-cell sequencing reveal TIME heterogeneity across disease stages and treatment strategies. The paper also evaluates immunotherapeutic approaches—immune checkpoint inhibitors, adoptive cell therapies, and therapeutic vaccines—covering mechanisms, clinical performance, and key challenges, integrating preclinical and clinical evidence to support translational targeting of TIME and improve outcomes for cervical cancer patients.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-immune-microenvironment-in-cervical-cancer-current-research-and-advances/369754/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-immune-microenvironment-in-cervical-cancer-current-research-and-advances/369754.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does the immune microenvironment play in cervical cancer?","Question",{"text":63,"@type":64},"The immune microenvironment is critical for cervical cancer pathogenesis and for determining treatment response, influencing tumor behavior and immune-mediated effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What components of the tumor immune microenvironment are emphasized in this review?",{"text":68,"@type":64},"The review focuses on immune cell infiltration patterns (such as T cells, B cells, NK cells, DCs, and TAMs), immune checkpoint molecules, and cytokine/chemokine networks.",{"name":70,"@type":61,"acceptedAnswer":71},"Which immunotherapeutic strategies are discussed?",{"text":72,"@type":64},"The review evaluates immune checkpoint inhibitors, adoptive cell therapies, and therapeutic vaccines, including their mechanisms, clinical efficacy, and challenges.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369754,1790238520,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Zhang et al. Journal of Translational Medicine (2025) 23:888  \n[https://doi.org/10.1186/s12967-025-06896-3](https://doi.org/10.1186/s12967-025-06896-3)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nTargeting immune microenvironment in cervical cancer: current research and advances  \nZhen Zhang 1†, Miao Liu2†, Yu An2†, Chongqing Gao 1, Tao Wang 1, Zhi Zhang 1, Guixiang Zhang 1, Shuo Li 1, Wei Li2*, Mengjia Li2* and Gangcheng Wang 1*  \nAbstract  \nThe immune microenvironment plays a critical role in pathogenesis and treatment response of cervical  \ncancer. This review comprehensively examines the cellular and molecular components of the tumor immune microenvironment (TIME) in cervical cancer, encompassing patterns of immune cell infiltration (T cells, B cells, NK cells, DCs, TAMs), immune checkpoint molecules, and cytokine/chemokine networks. We emphasize recent advances in understanding TIME heterogeneity, enabled by high-resolution spatial mapping and single-cell sequencing technologies, focusing specifically on differences across disease stages and treatment approaches. Thereview systematically evaluates immunotherapeutic strategies, such as immune checkpoint inhibitors, adoptive cell therapies, and therapeutic vaccines, discussing their mechanisms of action, clinical efficacy, and challenges. By synthesizing insights from both preclinical and clinical studies, our aim is to offer a translational perspective on targeting the TIME to enhance outcomes for cervical cancer patients.  \nKeywords Cervical cancer, Immune microenvironment, Immunotherapy, Immune checkpoint inhibitors  \n†Zhen Zhang, Miao Liu, and Yu An have been contributed equally to this work.  \n*Correspondence:  \nWei Li[zlyylw3028@zzu.edu.cn](zlyylw3028@zzu.edu.cn)[ ](zlyylw3028@zzu.edu.cn)Mengjia Li[limengjia921104@163.com](limengjia921104@163.com)[ ](limengjia921104@163.com)Gangcheng Wang [gangcheng07@hotmail.com](gangcheng07@hotmail.com)  \n1Department of Abdominal and Pelvic Tumor Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, China 2Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, China  \nIntroduction  \nCervical cancer is the fourth most common type of female malignancy and the fourth leading cause of cancer-related mortality among women on a global scale [1, 2]. In countries with a low Human Development Index (HDI), the morbidity and mortality rates are three and six times higher, respectively, than in high HDI countries [3]. Advances in prevention, such as human papillomavirus (HPV) vaccination, screening, and treatment have improved [4], therapeutic challenges remain—especially for patients with recurrent or metastatic disease. Approximately 20–30% of cases develop recurrence within 18–24 months after initial treatment, often with limited therapeutic options and poor prognosis [5, 6]. This typeof recurrence frequently occurs following treatment for advanced cervical cancer, making it more difficult to manage and associated with a poorer prognosis, thereby  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain pe","cbCail6JShojxa41","https://ap.wps.com/l/cbCail6JShojxa41","pdf",2577739,"English","# Introduction\n# The immune microenvironment in cervical cancer","[{\"question\":\"What role does the immune microenvironment play in cervical cancer?\",\"answer\":\"The immune microenvironment is critical for cervical cancer pathogenesis and for determining treatment response, influencing tumor behavior and immune-mediated effects.\"},{\"question\":\"What components of the tumor immune microenvironment are emphasized in this review?\",\"answer\":\"The review focuses on immune cell infiltration patterns (such as T cells, B cells, NK cells, DCs, and TAMs), immune checkpoint molecules, and cytokine/chemokine networks.\"},{\"question\":\"Which immunotherapeutic strategies are discussed?\",\"answer\":\"The review evaluates immune checkpoint inhibitors, adoptive cell therapies, and therapeutic vaccines, including their mechanisms, clinical efficacy, and challenges.\"}]","Targeting immune microenvironment in cervical cancer - current research and advances | PDF",1790184358,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c55224a31d28b17084562b58ff571f7.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b9f914ef4096aba61198b72acef2467.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/774e090a534edfb19a16c37dea52b3e9.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dd5f9109a6235f6e6a401d686f443cd.webp",980,1306]